What is Acute lymphocytic leukemia (ALL)

Acute lymphocytic leukemia (ALL) is a fast-growing cancer of the blood and bone marrow in which the body produces an excessive number of immature white blood cells called lymphoblasts. Because these cells do not function properly, they crowd out healthy blood cells, leading to symptoms like anemia, infection, and bleeding.

What exactly happens in the body with Acute lymphocytic leukemia (ALL)?

In Acute lymphocytic leukemia (ALL), the bone marrow—the spongy tissue inside bones—begins producing abnormal, immature lymphocytes. These "leukemic blasts" multiply rapidly and fail to mature into functional white blood cells. As they accumulate in the bone marrow, they suppress the production of healthy red blood cells, normal white blood cells, and platelets. This systemic disruption affects the immune system, oxygen transport, and the body's ability to clot blood.

Who is most commonly affected by Acute lymphocytic leukemia (ALL)?

Acute lymphocytic leukemia (ALL) is the most common form of cancer in children, with a peak incidence between the ages of 2 and 5. While it is primarily a pediatric diagnosis, it can affect individuals of any age. Statistics from the NIH indicate that while pediatric survival rates are high (often exceeding 90%), the prognosis can be more challenging in adult populations.

How is Acute lymphocytic leukemia (ALL) classified?

Physicians categorize Acute lymphocytic leukemia (ALL) based on the type of lymphocyte involved and specific genetic markers. The main classifications include:

• B-cell ALL: The most common subtype, accounting for approximately 75% of cases.


• T-cell ALL: A less common subtype that often presents with a mass in the chest.


• Philadelphia chromosome-positive (Ph+) ALL: A specific genetic subtype characterized by a translocation between chromosomes 9 and 22, which requires targeted therapy.

What differentiates Acute lymphocytic leukemia (ALL) from other leukemias?

Unlike chronic leukemias, which progress slowly, Acute lymphocytic leukemia (ALL) is characterized by its rapid, aggressive progression. It is specifically distinguished from Acute Myeloid Leukemia (AML) by the lineage of the malignant cells; in Acute lymphocytic leukemia (ALL), the cells are of the lymphoid lineage, whereas AML involves the myeloid (blood-forming) lineage.

Next steps

• Consult a hematologist-oncologist to discuss diagnostic bone marrow biopsy results.


• Connect with the 9 community members on DiseaseMaps.org to share experiences and find support.


• Inquire with your medical team about current clinical trials and precision medicine options for your specific genetic subtype.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician.

References

• NIH Genetic and Rare Diseases (GARD) Information Center


• Orphanet: Portal for rare diseases and orphan drugs


• American Cancer Society: ALL Overview


• Leukemia & Lymphoma Society (LLS)